BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12075777)

  • 1. Dose of Calmette-Guérin bacillus vaccination in infants.
    Gür E; Arvas A
    Pediatr Infect Dis J; 2002 Apr; 21(4):359-60. PubMed ID: 12075777
    [No Abstract]   [Full Text] [Related]  

  • 2. What does tuberculin reactivity after bacille Calmette-Guérin vaccination tell us?
    Menzies D
    Clin Infect Dis; 2000 Sep; 31 Suppl 3():S71-4. PubMed ID: 11010826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of tuberculin induration with the number of Bacillus Calmette-Guérin vaccines.
    Ildirim I; Hacimustafaoğlu M; Ediz B
    Pediatr Infect Dis J; 1995 Dec; 14(12):1060-3. PubMed ID: 8745018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between Bacillus Calmette-Guérin vaccination (1331 SSI) skin reaction and subsequent scar development in infants.
    Birk NM; Nissen TN; Ladekarl M; Zingmark V; Kjærgaard J; Jensen TM; Jensen SK; Thøstesen LM; Kofoed PE; Stensballe LG; Andersen A; Pryds O; Nielsen SD; Benn CS; Jeppesen DL
    BMC Infect Dis; 2017 Aug; 17(1):540. PubMed ID: 28774269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity and safety of early vs delayed BCG vaccination in moderately preterm (31-33 weeks) infants.
    Saroha M; Faridi MM; Batra P; Kaur I; Dewan DK
    Hum Vaccin Immunother; 2015; 11(12):2864-71. PubMed ID: 26431252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [BCG vaccination of medical students of the University of Naples: findings concerning the evolution of the vaccination site and the BCG allergy].
    Galzerano G; Dericoloso A; Goatley ML; Mazzarella G
    Arch Monaldi; 1980; 35(3):143-7. PubMed ID: 7316664
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of number of BCG vaccination on tuberculin induration size.
    Gundogdu Z; Aydogan M; Arisoy ES; Gokalp AS
    J Paediatr Child Health; 2007 Jun; 43(6):476-9. PubMed ID: 17535179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and immunogenicity of Bacillus Calmette-Guerin vaccine in children born to HIV-1 infected women.
    Thaithumyanon P; Thisyakorn U; Punnahitananda S; Praisuwanna P; Ruxrungtham K
    Southeast Asian J Trop Med Public Health; 2000 Sep; 31(3):482-6. PubMed ID: 11289006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of bacille Calmette-Guérin vaccination at birth on immune response in China.
    Pang Y; Kang W; Zhao A; Liu G; Du W; Xu M; Wang G; Zhao Y; Zheng S
    Vaccine; 2015 Jan; 33(1):209-13. PubMed ID: 25454854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low birth weight infants and Calmette-Guérin bacillus vaccination at birth: community study from Guinea-Bissau.
    Roth A; Jensen H; Garly ML; Djana Q; Martins CL; Sodemann M; Rodrigues A; Aaby P
    Pediatr Infect Dis J; 2004 Jun; 23(6):544-50. PubMed ID: 15194836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of Bacille Calmette-Guérin vaccine on tuberculin reactivity in indigenous children from communities with high prevalence of tuberculosis.
    Araujo Z; de Waard JH; de Larrea CF; Borges R; Convit J
    Vaccine; 2008 Oct; 26(44):5575-81. PubMed ID: 18723065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recommendations for pediatric tuberculosis vaccination in Italy.
    Montagnani C; Esposito S; Galli L; Chiappini E; Principi N; de Martino M;
    Hum Vaccin Immunother; 2016 Mar; 12(3):644-50. PubMed ID: 26587764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of BCG at birth in the United Arab Emirates.
    Sedaghatian MR; Shana'a IA
    Tubercle; 1990 Sep; 71(3):177-80. PubMed ID: 2238123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective study of bacillus Calmette-Guérin scar formation and tuberculin skin test reactivity in infants in Lima, Peru.
    Santiago EM; Lawson E; Gillenwater K; Kalangi S; Lescano AG; Du Quella G; Cummings K; Cabrera L; Torres C; Gilman RH
    Pediatrics; 2003 Oct; 112(4):e298. PubMed ID: 14523215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating Bacillus-Calmette-Guerin vaccination by tuberculin skin test response.
    Uyan AP; Baskin E; Büyükbese E; Gökalp AS
    Indian Pediatr; 2000 Oct; 37(10):1106-10. PubMed ID: 11042711
    [No Abstract]   [Full Text] [Related]  

  • 16. Early versus late BCG vaccination in HIV-1-exposed infants in Uganda: study protocol for a randomized controlled trial.
    Nankabirwa V; Tumwine JK; Namugga O; Tylleskär T; Ndeezi G; Robberstad B; Netea MG; Sommerfelt H
    Trials; 2017 Mar; 18(1):152. PubMed ID: 28359325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of vitamin A combined vitamin D supplementation on immune response to Bacille Calmette-Guérin vaccine revaccinated in Chinese infants.
    Zheng Y; Li XG; Wang QZ; Ma AG; Bygbjerg IC; Sun YY; Li Y; Zheng MC; Wang X
    Asian Pac J Trop Med; 2014 Feb; 7(2):130-5. PubMed ID: 24461526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Timing and dose of BCG vaccination in infants as assessed by postvaccination tuberculin sensitivity.
    Aggarwal A; Dutta AK
    Indian Pediatr; 1995 Jun; 32(6):635-9. PubMed ID: 8613331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacillus Calmette-Guérin immunization in infants born to HIV-1-seropositive mothers.
    Lallemant-Le Coeur S; Lallemant M; Cheynier D; Nzingoula S; Drucker J; Larouze B
    AIDS; 1991 Feb; 5(2):195-9. PubMed ID: 2031692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Post-vaccination tuberculin response using PPD derived from BCG].
    Sarinho E; Pontual M; Carvalho MR; da Costa MJ
    Bol Oficina Sanit Panam; 1991 Nov; 111(5):402-5. PubMed ID: 1837717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.